Replay available

PAVmed Inc. (PAVM) Q2 2026 Earnings Call

PAVmed Inc. (NASDAQ: PAVM) Q2 2026 earnings conference call, held 2026-08-14. Replay captured from the company's public earnings webcast.

Fri, August 14, 2026 at 8:30 AMendedReplay
PAVmed Inc. (PAVM) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matt Riley

Vice President of Investor Relations

Dr. Lishan Aklog

Chairman and Chief Executive Officer

Dennis McGrath

Chief Financial Officer

Ed Wu

Analyst, Ascendant Capital

Jeremy Pearlman

Analyst, Maxim Group

Replay transcript excerpt

Good morning and welcome to the PAVMED second quarter 2026 business update conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. Please note, this event is being recorded. I would now like to turn the conference over to Matt Riley, PAVMED's Vice President of Investor Relations. Please go ahead. Thank you, operator, and good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PABMED, along with Dennis McGrath, Chief Financial Officer. The press release announcing our business update and financial results is available on PABMED's website. Please take a moment to read the disclaimers about Florida Green Statements in the press release. The business update, press release, and conference call all include Florida Green Statements, and these Florida Green Statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and a description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A, entitled Risk Factors and PADMED's Most Recent Annual Report on Forms 10-K filed with the SEC, and any subsequent updates filed in quarter reports on Forms 10-Q and subsequent Forms 8-K. Steps as required by law of PADMED disclaims any intentions or obligations to publicly update or advise any forward opening statements to reflec...

More from Pavmed Inc.